Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gannon

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
The American Journal of Psychiatry|January 4, 2001
A novel augmentation strategy for treating resistant major depressionR C Shelton, G D Tollefson, M Tohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunitP D Calvert, N V Krasnoperova, A L Lyubarsky, et al.
Archives of General Psychiatry|October 4, 2000
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study GroupJ S Street, W S Clark, K S Gannon, et al.
Nature Communications|April 2, 2022
Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cellsHugh S Gannon, Tao Zou, Michael K Kiessling, et al.
Nature Communications|December 22, 2018
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cellsHugh S Gannon, Tao Zou, Michael K Kiessling, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
NPT088 reduces both amyloid-β and tau pathologies in transgenic miceJonathan M Levenson, Sally Schroeter, Jenna C Carroll, et al.
Irish Medical Journal|December 7, 2018
The Doctor Can See You Now: A Key Stakeholder Study Into The Acceptability Of Ambulance Based TelemedicineP Gilligan, A Bennett, A Houlihan, et al.
The Journal of Clinical Investigation|December 15, 2023
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screensMichael R Schlabach, Sharon Lin, Zachary R Collester, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The American Journal of Psychiatry|January 4, 2001
A novel augmentation strategy for treating resistant major depressionR C Shelton, G D Tollefson, M Tohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunitP D Calvert, N V Krasnoperova, A L Lyubarsky, et al.
Archives of General Psychiatry|October 4, 2000
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study GroupJ S Street, W S Clark, K S Gannon, et al.
Nature Communications|April 2, 2022
Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cellsHugh S Gannon, Tao Zou, Michael K Kiessling, et al.
Nature Communications|December 22, 2018
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cellsHugh S Gannon, Tao Zou, Michael K Kiessling, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
NPT088 reduces both amyloid-β and tau pathologies in transgenic miceJonathan M Levenson, Sally Schroeter, Jenna C Carroll, et al.
Irish Medical Journal|December 7, 2018
The Doctor Can See You Now: A Key Stakeholder Study Into The Acceptability Of Ambulance Based TelemedicineP Gilligan, A Bennett, A Houlihan, et al.
The Journal of Clinical Investigation|December 15, 2023
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screensMichael R Schlabach, Sharon Lin, Zachary R Collester, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Pageof 5